JP2024515936A5 - - Google Patents
Info
- Publication number
- JP2024515936A5 JP2024515936A5 JP2023556950A JP2023556950A JP2024515936A5 JP 2024515936 A5 JP2024515936 A5 JP 2024515936A5 JP 2023556950 A JP2023556950 A JP 2023556950A JP 2023556950 A JP2023556950 A JP 2023556950A JP 2024515936 A5 JP2024515936 A5 JP 2024515936A5
- Authority
- JP
- Japan
- Prior art keywords
- ribonucleic acid
- guide
- sequence
- manipulated
- class
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163163510P | 2021-03-19 | 2021-03-19 | |
| US63/163,510 | 2021-03-19 | ||
| US202163186506P | 2021-05-10 | 2021-05-10 | |
| US63/186,506 | 2021-05-10 | ||
| US202163241916P | 2021-09-08 | 2021-09-08 | |
| US63/241,916 | 2021-09-08 | ||
| PCT/US2022/021004 WO2022198080A1 (en) | 2021-03-19 | 2022-03-18 | Multiplex editing with cas enzymes |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024515936A JP2024515936A (ja) | 2024-04-11 |
| JP2024515936A5 true JP2024515936A5 (enExample) | 2025-03-25 |
| JP7877351B2 JP7877351B2 (ja) | 2026-06-22 |
Family
ID=83321225
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023556950A Active JP7877351B2 (ja) | 2021-03-19 | 2022-03-18 | Ｃａｓ酵素を用いたマルチプレックス編集 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20250075233A1 (enExample) |
| EP (1) | EP4308699A4 (enExample) |
| JP (1) | JP7877351B2 (enExample) |
| KR (1) | KR20230157387A (enExample) |
| AU (1) | AU2022237663A1 (enExample) |
| BR (1) | BR112023018948A2 (enExample) |
| CA (1) | CA3210361A1 (enExample) |
| MX (1) | MX2023010969A (enExample) |
| WO (1) | WO2022198080A1 (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2021178933A2 (en) | 2020-03-06 | 2021-09-10 | Metagenomi Ip Technologies, Llc | Class ii, type v crispr systems |
| US10913941B2 (en) | 2019-02-14 | 2021-02-09 | Metagenomi Ip Technologies, Llc | Enzymes with RuvC domains |
| CN116096892A (zh) * | 2020-05-08 | 2023-05-09 | 宏基因组学公司 | 具有RuvC结构域的酶 |
| KR20230134543A (ko) * | 2021-01-22 | 2023-09-21 | 메타지노미, 인크. | 신규한 조작된 뉴클레아제 및 키메라 뉴클레아제 |
| CN119452085A (zh) | 2021-08-27 | 2025-02-14 | 宏基因组学公司 | 具有ruvc结构域的酶 |
| KR20240110603A (ko) | 2021-11-24 | 2024-07-15 | 메타지노미, 인크. | 엔도뉴클레아제 시스템 |
| WO2024127370A1 (en) * | 2022-12-16 | 2024-06-20 | LifeEDIT Therapeutics, Inc. | Guide rnas that target trac gene and methods of use |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2003233634A1 (en) | 2002-05-20 | 2003-12-12 | Pharmacia Corporation | Antisense modulation of glucocorticoid receptor expression |
| US20150017136A1 (en) | 2013-07-15 | 2015-01-15 | Cellectis | Methods for engineering allogeneic and highly active t cell for immunotherapy |
| JP6608807B2 (ja) * | 2013-05-29 | 2019-11-20 | セレクティス | Ｒｎａガイドｃａｓヌクレアーゼ系を用いることによって免疫療法のためにｔ細胞を操作するための方法 |
| AU2016262093B2 (en) | 2015-05-13 | 2022-08-18 | Seattle Children' S Hospital (Dba Seattle Children 's Research Institute) | Enhancing endonuclease based gene editing in primary cells |
| MX2018010484A (es) | 2016-03-04 | 2019-01-10 | Editas Medicine Inc | Métodos, composiciones y componentes relacionados con crispr-cpf1 para la inmunoterapia contra el cáncer. |
| BR112019023608A2 (pt) | 2017-05-12 | 2020-05-26 | Crispr Therapeutics Ag | Materiais e métodos para células manipuladas e seus usos em imuno-oncologia |
| EP3686275A4 (en) | 2017-09-18 | 2021-09-29 | Edigene Inc. | GENE EDITING LYMPHOCYTE T AND RELATED USE |
| US12359223B2 (en) * | 2018-01-30 | 2025-07-15 | Editas Medicine, Inc. | Systems and methods for modulating chromosomal rearrangements |
| US12275951B2 (en) | 2018-02-06 | 2025-04-15 | Ohio State Innovation Foundation | Engineered guide RNA and uses thereof |
| BR112020015488A2 (pt) | 2018-02-08 | 2020-12-08 | Sangamo Therapeutics, Inc. | Nucleases alvo-específicas modificadas |
| KR20240007322A (ko) * | 2019-02-14 | 2024-01-16 | 메타지노미, 인크. | Ruvc 도메인이 존재하는 효소 |
| US10913941B2 (en) * | 2019-02-14 | 2021-02-09 | Metagenomi Ip Technologies, Llc | Enzymes with RuvC domains |
| EP3938510A1 (en) | 2019-03-11 | 2022-01-19 | Sorrento Therapeutics, Inc. | Improved process for integration of dna constructs using rna-guided endonucleases |
| GB201907733D0 (en) * | 2019-05-31 | 2019-07-17 | Governing Council Of The Univ Of Toronto | Methods and compositions for multiplex gene editing |
-
2022
- 2022-03-18 JP JP2023556950A patent/JP7877351B2/ja active Active
- 2022-03-18 EP EP22772310.3A patent/EP4308699A4/en not_active Withdrawn
- 2022-03-18 MX MX2023010969A patent/MX2023010969A/es unknown
- 2022-03-18 WO PCT/US2022/021004 patent/WO2022198080A1/en not_active Ceased
- 2022-03-18 CA CA3210361A patent/CA3210361A1/en active Pending
- 2022-03-18 BR BR112023018948A patent/BR112023018948A2/pt active Search and Examination
- 2022-03-18 AU AU2022237663A patent/AU2022237663A1/en active Pending
- 2022-03-18 KR KR1020237034371A patent/KR20230157387A/ko active Pending
-
2023
- 2023-09-01 US US18/459,729 patent/US20250075233A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Restrepo et al. | Antigen diversity in the bacterium B. hermsii through “somatic” mutations in rearranged vmp genes | |
| JP2023533417A5 (enExample) | ||
| EP2248914A1 (en) | The use of class IIB restriction endonucleases in 2nd generation sequencing applications | |
| Pascale et al. | Amplification of an ancestral mammalian L1 family of long interspersed repeated DNA occurred just before the murine radiation. | |
| Gotoh et al. | Locations of frequently opening regions on natural DNAs and their relation to functional loci | |
| JPH07507201A (ja) | 可変鋳型反応 | |
| Simmons et al. | Five novel genes from the cri-du-chat critical region isolated by direct selection | |
| US20200299764A1 (en) | System and method for transposase-mediated amplicon sequencing | |
| MXPA04008373A (es) | Metodo para reduccion de errores en poblaciones de acido nucleico. | |
| JP2024541811A5 (enExample) | ||
| JP2022533366A (ja) | プライマー認識が改良されたＰｈｉ２９ ＤＮＡポリメラーゼ変異体 | |
| AU2023275773A1 (en) | Preparation of long read nucleic acid libraries | |
| Rougeon et al. | Cloning and amplification of rabbit alpha-and beta-globin gene sequences into Escherichia coli plasmids. | |
| JP2024534639A5 (enExample) | ||
| Bonavita et al. | The evolutionary conservation of rps3 introns and rps19-rps3-rpl16 gene cluster in Adiantum capillus-veneris mitochondria | |
| US20180346963A1 (en) | Preparation of Concatenated Polynucleotides | |
| Barth et al. | Polycistronic transcription and editing of the mitochondrial small subunit (SSU) ribosomal RNA in Dictyostelium discoideum | |
| CN118360314A (zh) | 紫花苜蓿CRISPR/Cas9多靶点编辑系统及其应用 | |
| CN113493803B (zh) | 紫花苜蓿CRISPR/Cas9基因组编辑系统及其应用 | |
| US20260103724A1 (en) | Vector for multi-gene base editing, editing method, and use | |
| Winkfein et al. | A new family of repetitive, retroposon‐like sequences in the genome of the rainbow trout | |
| US20220259632A1 (en) | Method of oligonucleotide synthesis | |
| Schuster | Ribosomal protein gene rpl5 is cotranscribed with the nad3 gene in Oenothera mitochondria | |
| EP4499849A1 (en) | Production of reverse transcribed dna (rt-dna) using a retron reverse transcriptase from exogenous rna | |
| Game et al. | An integrated map of human 6q22. 3–q24 including a 3-Mb high-resolution BAC/PAC contig encompassing a QTL for fetal hemoglobin |